Viscoelastic Properties of Hyaluronan in Physiological Conditions

Mary K Cowman, Tannin A Schmidt, Preeti Raghavan, Antonio Stecco, Mary K Cowman, Tannin A Schmidt, Preeti Raghavan, Antonio Stecco

Abstract

Hyaluronan (HA) is a high molecular weight glycosaminoglycan of the extracellular matrix (ECM), which is particularly abundant in soft connective tissues. Solutions of HA can be highly viscous with non-Newtonian flow properties. These properties affect the movement of HA-containing fluid layers within and underlying the deep fascia. Changes in the concentration, molecular weight, or even covalent modification of HA in inflammatory conditions, as well as changes in binding interactions with other macromolecules, can have dramatic effects on the sliding movement of fascia. The high molecular weight and the semi-flexible chain of HA are key factors leading to the high viscosity of dilute solutions, and real HA solutions show additional nonideality and greatly increased viscosity due to mutual macromolecular crowding. The shear rate dependence of the viscosity, and the viscoelasticity of HA solutions, depend on the relaxation time of the molecule, which in turn depends on the HA concentration and molecular weight. Temperature can also have an effect on these properties. High viscosity can additionally affect the lubricating function of HA solutions. Immobility can increase the concentration of HA, increase the viscosity, and reduce lubrication and gliding of the layers of connective tissue and muscle. Over time, these changes can alter both muscle structure and function. Inflammation can further increase the viscosity of HA-containing fluids if the HA is modified via covalent attachment of heavy chains derived from Inter-α-Inhibitor. Hyaluronidase hydrolyzes HA, thus reducing its molecular weight, lowering the viscosity of the extracellular matrix fluid and making outflow easier. It can also disrupt any aggregates or gel-like structures that result from HA being modified. Hyaluronidase is used medically primarily as a dispersion agent, but may also be useful in conditions where altered viscosity of the fascia is desired, such as in the treatment of muscle stiffness.

Keywords: fascia; hyaluronan; lubrication; viscoelasticity; viscosity.

Conflict of interest statement

Competing interests: No competing interests were disclosed.

Figures

Figure 1.. The hydrodynamic size of a…
Figure 1.. The hydrodynamic size of a hyaluronan chain depends on its molecular weight.
Hyaluronan chains with molecular weight of (from left to right) 0.1, 0.5, 1, 3 and 6 million have hydrodynamic diameters of approximately 50, 140, 210, 400, and 600 nm, respectively in physiological saline solution. The diameter of a small globular protein would be on the order of a few nm. Adapted from Cowman and Matsuoka .
Figure 2.. Specific viscosity of hyaluronan solutions,…
Figure 2.. Specific viscosity of hyaluronan solutions, as a function of the concentration and intrinsic viscosity [η].
Experimental data for hyaluronan in physiological saline, plotted using the fitted equationη sp =c[η] + 0.42(c[η])2 + 7.77 x 10 -3(c[η])4.18 reported by Berriaud and coworkers , shows a marked increase in viscosity with increasing concentration and intrinsic viscosity. (Note that this data represents low shear conditions, where hyaluronan chains are not distorted or aligned with flow.) The experimental data can be compared with predictions based on theory. For an ideal case in which the hyaluronan molecules act independently, the specific viscosity would simply be equal to the productc[η]. When the molecules become crowded, the effective concentration increases, leading to a significant nonideality contribution, predicted by the last three terms of the mutual macromolecular crowding equation, ( Equation 2 in text).
Figure 3.. Model for steric exclusion of…
Figure 3.. Model for steric exclusion of a globular protein by a hyaluronan molecule.
A illustrates the ability of small globular proteins to penetrate most of the hydrodynamic domain of the hyaluronan polymer.B shows the size of the excluded volume for a globular protein in the presence of a segment of a linear polymer as a crowding agent. The cross section of the cylindrical excluded volume has a radius equal to the sum of the radius of the crowding polymer and the thickness of a cylindrical shell determined by the radius of the globular protein. This figure has been reproduced with permission from Cowmanet al. (2012) in Structure and Function of Biomatrix. Control of Cell Behavior and Gene Expression. Ed. E.A. Balazs, pp.45–66. Copyright 2012 Matrix Biology Institute.
Figure 4.. Model for mutual macromolecular crowding…
Figure 4.. Model for mutual macromolecular crowding of hyaluronan molecules.
The effective hydrodynamic domain of each chain is modeled as a sphere, the volume of which is dependent on the molecular weight to the 1.8 power. This figure has been reproduced with permission from Cowmanet al. (2012) in Structure and Function of Biomatrix. Control of Cell behavior and Gene Expression. Ed. E.A. Balazs, pp.45–66. Copyright 2012 Matrix Biology Institute.
Figure 5.. Shear rate dependence of the…
Figure 5.. Shear rate dependence of the viscosity of a polydisperse hyaluronan sample (viscosity-average molecular weight = 1.7 million) at a concentration of 5 mg/ml in PBS at 25°C.
Data from three consecutive runs are shown. This figure has been reproduced with permission from Cowmanet al. (2011) Anal. Biochem., 417, 50–56. Copyright 2011 Elsevier Inc.
Figure 6.. Master curves for the elastic…
Figure 6.. Master curves for the elastic modulus (G') and the viscous modulus (G") of a solution of HA with a molecular weight of 2.8 x 10 6 as a function of the frequency of displacement.
This figure has been reproduced with permission from Gibbset al. Biopolymers1968, 6, 777–791. Copyright 1968 John Wiley & Sons, Inc.
Figure 7.. Friction coefficient plotted as a…
Figure 7.. Friction coefficient plotted as a function of fluid viscosity and shear velocity divided by load (Stribeck curve) with corresponding lubrication film thickness.
The schematic shows boundary, mixed, and hydrodynamic lubrication regimes. This figure has been reproduced with permission from Coleset al. (2010) Curr. Opin. Colloid Interface Sci. 15, 406–416. Copyright 2010 Elsevier Ltd.
Figure 8.. Dependence of the cartilage boundary…
Figure 8.. Dependence of the cartilage boundary lubricating properties of hyaluronan alone at 3.33 mg/ml on molecular weight.
Regression lines are shown for (A) mean static µ static, Neq friction values at pre-sliding duration, T ps = 1,200 s, and (B) mean kinetic <µ kinetic, Neq> friction values at T ps = 1.2 s obtained vs log molecular weight of hyaluronan. Mean values in phosphate-buffered saline (PBS) and synovial fluid (SF) are shown for reference. This figure has been reproduced with permission from Kwiecinskiet al. (2011) Osteoarthritis Cartilage 19, 1356–1362. Copyright 2011 Osteoarthritis Research Society International.
Figure 9.. Lubricin (rhPRG4) can reduce the…
Figure 9.. Lubricin (rhPRG4) can reduce the viscosity of HA (weight-average molecular weight of 1.5 million) solution when both are present at concentrations found in normal human synovial fluid.
Shear rate dependent specific viscosity at 25°C of hyaluronan at 3.3 mg/ml alone and with 450 μg/ml rhPRG4, shown in black. Predicted specific viscosity (experimental hyaluronan + experimental rhPRG4) shown in red. This figure has been reproduced with permission from Ludwiget al. (2014) Biorheology 51, 409–422. Copyright 2014 IOS Press and the authors.

References

    1. Laurent TC, Fraser JR: Hyaluronan. FASEB J. 1992;6(7):2397–404.
    1. Cowman MK, Lee HG, Schwertfeger KL, et al. : The Content and Size of Hyaluronan in Biological Fluids and Tissues. Front Immunol. 2015;6:261. 10.3389/fimmu.2015.00261
    1. Fraser JR, Laurent TC, Laurent UB: Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 1997;242(1):27–33. 10.1046/j.1365-2796.1997.00170.x
    1. Tammi MI, Day AJ, Turley EA: Hyaluronan and homeostasis: a balancing act. J Biol Chem. 2002;277(7):4581–4. 10.1074/jbc.R100037200
    1. Li M, Rosenfeld L, Vilar RE, et al. : Degradation of hyaluronan by peroxynitrite. Arch Biochem Biophys. 1997;341(2):245–50. 10.1006/abbi.1997.9970
    1. Stern R, Kogan G, Jedrzejas MJ, et al. : The many ways to cleave hyaluronan. Biotechnol Adv. 2007;25(6):537–57. 10.1016/j.biotechadv.2007.07.001
    1. Volpi N, Schiller N, Stern R, et al. : Role, metabolism, chemical modifications and applications of hyaluronan. Curr Med Chem. 2009;16(14):1718–45. 10.2174/092986709788186138
    1. Balazs EA: Viscoelastic properties of hyaluronic acid and biological lubrication. Univ Mich Med Cent J. 1968:255–9.
    1. Laurent TC, Laurent UB, Fraser JR: The structure and function of hyaluronan: An overview. Immunol Cell Biol. 1996;74(2):A1–7. 10.1038/icb.1996.32
    1. Piehl-Aulin K, Laurent C, Engström-Laurent A, et al. : Hyaluronan in human skeletal muscle of lower extremity: concentration, distribution, and effect of exercise. J Appl Physiol (1985). 1991;71(6):2493–8.
    1. Laurent C, Johnson-Wells G, Hellström S, et al. : Localization of hyaluronan in various muscular tissues. A morphological study in the rat. Cell Tissue Res. 1991;263(2):201–5. 10.1007/BF00318761
    1. McCombe D, Brown T, Slavin J, et al. : The histochemical structure of the deep fascia and its structural response to surgery. J Hand Surg Br. 2001;26(2):89–97. 10.1054/jhsb.2000.0546
    1. Benetazzo L, Bizzego A, De Caro R, et al. : 3D reconstruction of the crural and thoracolumbar fasciae. Surg Radiol Anat. 2011;33(10):855–62. 10.1007/s00276-010-0757-7
    1. Lancerotto L, Stecco C, Macchi V, et al. : Layers of the abdominal wall: anatomical investigation of subcutaneous tissue and superficial fascia. Surg Radiol Anat. 2011;33(10):835–42. 10.1007/s00276-010-0772-8
    1. Stecco C, Porzionato A, Lancerotto L, et al. : Histological study of the deep fasciae of the limbs. J Bodyw Mov Ther. 2008;12(3):225–30. 10.1016/j.jbmt.2008.04.041
    1. Stecco C, Pavan PG, Porzionato A, et al. : Mechanics of crural fascia: from anatomy to constitutive modelling. Surg Radiol Anat. 2009;31(7):523–9. 10.1007/s00276-009-0474-2
    1. Stecco C, Stern R, Porzionato A, et al. : Hyaluronan within fascia in the etiology of myofascial pain. Surg Radiol Anat. 2011;33(10):891–6. 10.1007/s00276-011-0876-9
    1. Cowman MK, Matsuoka S: Experimental approaches to hyaluronan structure. Carbohydr Res. 2005;340(5):791–809. 10.1016/j.carres.2005.01.022
    1. Balazs EA: Amino sugar-containing macromolecules in the tissues of the eye and the ear. In The Amino Sugars: The Chemistry and Biology of Compounds Containing Amino Sugars EA Balazs, Jeanloz RW, Editor. Academic Press: New York,1965;401–460. 10.1016/B978-1-4832-2927-0.50028-2
    1. Cowman MK, Matsuoka S: The Intrinsic Viscosity of Hyaluronan. In Hyaluronan JF Kennedy, Phillips GO, Williams PA, Hascall VC, Editor. Woodhead Publishing Ltd. Cambridge,2002;75–78. 10.1533/9781845693121.75
    1. Berriaud N, Milas M, Rinaudo M: Rheological study on mixtures of different molecular weight hyaluronates. Int J Biol Macromol. 1994;16(3):137–42. 10.1016/0141-8130(94)90040-X
    1. Matsuoka S, Cowman MK: Equation of state for polymer solution. Polymer. 2002;43(12):3447–3453. 10.1016/S0032-3861(02)00157-X
    1. Cowman MK, Hernandez M, Kim JR, et al. : Macromolecular Crowding in the Biomatrix. In Structure and function of Biomatrix. Control of Cell Behavior and Gene Expression EA Balazs, Editor. Matrix Biology Institute: Edgewater, NJ,2012;45–66.
    1. Cowman MK, Mendichi R: Methods for Determination of Hyaluronan Molecular Weight. In Chemistry and Biology of Hyaluronan, HG Garg and CA Hales, Editors. Elsevier: Amsterdam,2004;41–69. 10.1016/B978-008044382-9/50034-0
    1. Ogston AG: The Spaces in a Uniform Random Suspension of Fibres. Trans Faraday Soc. 1958;54(11):1754–1757. 10.1039/TF9585401754
    1. Laurent TC, Killander J: A theory of gel filtration and its experimental verification. J Chromatogr. 1964;14(3):317–330. 10.1016/S0021-9673(00)86637-6
    1. Laurent TC: The interaction between polysaccharides and other macromolecules. 9. The exclusion of molecules from hyaluronic acid gels and solutions. Biochem J. 1964;93(1):106–12.
    1. Gribbon P, Heng BC, Hardingham TE: The molecular basis of the solution properties of hyaluronan investigated by confocal fluorescence recovery after photobleaching. Biophys J. 1999;77(4):2210–6. 10.1016/S0006-3495(99)77061-X
    1. Gribbon P, Heng BC, Hardingham TE: The analysis of intermolecular interactions in concentrated hyaluronan solutions suggest no evidence for chain-chain association. Biochem J. 2000;350(Pt 1):329–35. 10.1042/bj3500329
    1. Cleland RL: Effect of Temperature on the Limiting Viscosity Number of Hyaluronic Acid and Chondroitin 4-Sulfate. Biopolymers. 1979;18(7):1821–1828. 10.1002/bip.1979.360180718
    1. Fouissac E, Milas M, Rinaudo M: Shear-rate, Concentration, Molecular Weight, and Temperature Viscosity Dependencies of Hyaluronate, a Wormlike Polyelectrolyte. Macromolecules. 1993;26(25):6945–6951. 10.1021/ma00077a036
    1. Hoefling JM, Cowman MK, Matsuoka S, et al. : Temperature Effect on the Dynamic Rheological Characteristics of Hyaluronan, Hylan A and Synvisc®. In Hyaluronan, JF Kennedy, Phillips GO, Williams PA, Hascall VC, Editor. Woodhead Publishing Ltd, Cambridge,2002;103–108. 10.1533/9781845693121.109
    1. Morris ER, Rees DA, Welsh EJ: Conformation and dynamic interactions in hyaluronate solutions. J Mol Biol. 1980;138(2):383–400. 10.1016/0022-2836(80)90294-6
    1. Mathews MB, Decker L: Conformation of hyaluronate in neutral and alkaline solutions. Biochim Biophys Acta. 1977;498(1):259–63. 10.1016/0304-4165(77)90107-6
    1. Gatej I, Popa M, Rinaudo M: Role of the pH on hyaluronan behavior in aqueous solution. Biomacromolecules. 2005;6(1):61–7. 10.1021/bm040050m
    1. Pigman W, Hawkins W, Gramling E, et al. : Factors affecting the viscosity of hyaluronic acid and synovial fluid. Arch Biochem Biophys. 1960;89:184–93. 10.1016/0003-9861(60)90041-2
    1. Balazs EA: Sediment volume and viscoelastic behavior of hyaluronic acid solutions. Fed Proc. 1966;25(6):1817–22.
    1. Balazs EA, Cowman MK, Briller SO, et al. : On the Limiting Viscosity Number of Hyaluronate in Potassium Phosphate Buffers Between pH 6.5 and 8. Biopolymers. 1983;22(2):589–591. 10.1002/bip.360220202
    1. Cowman MK, Chen CC, Pandya M, et al. : Improved agarose gel electrophoresis method and molecular mass calculation for high molecular mass hyaluronan. Anal Biochem. 2011;417(1):50–6. 10.1016/j.ab.2011.05.023
    1. Gibbs DA, Merrill EW, Smith KA, et al. : Rheology of hyaluronic acid. Biopolymers. 1968;6(6):777–91. 10.1002/bip.1968.360060603
    1. Coles JM, Chang DP, Zauscher S: Molecular mechanisms of aqueous boundary lubrication by mucinous glycoproteins. Curr Opin Colloid In Sci. 2010;15(6):406–416. 10.1016/j.cocis.2010.07.002
    1. Dunn AC, Sawyer WG, Angelini TE: Gemini Interfaces in Aqueous Lubrication with Hydrogels. Tribol Lett. 2014;54(1):59–66. 10.1007/s11249-014-0308-1
    1. Kwiecinski JJ, Dorosz SG, Ludwig TE, et al. : The effect of molecular weight on hyaluronan's cartilage boundary lubricating ability--alone and in combination with proteoglycan 4. Osteoarthritis Cartilage. 2011;19(11):1356–62. 10.1016/j.joca.2011.07.019
    1. Yakubov GE, McColl J, Bongaerts JH, et al. : Viscous boundary lubrication of hydrophobic surfaces by mucin. Langmuir. 2009;25(4):2313–21. 10.1021/la8018666
    1. Ludwig TE, Cowman MK, Jay GD, et al. : Effects of concentration and structure on proteoglycan 4 rheology and interaction with hyaluronan. Biorheology. 2014;51(6):409–22. 10.3233/BIR-14037
    1. Torihashi S, Ho M, Kawakubo Y, et al. : Acute and Temporal Expression of TNF-α-stimulated Gene 6 Product,TSG-6,in Mesenchymal Stem Cells Creates Microenvironments Required for Their Successul Transplantation into the Muscle Tissue. J Biol Chem. 2015. 10.1074/jbc.M114.629774
    1. Milner CM, Higman VA, Day AJ: TSG-6: a pluripotent inflammatory mediator? Biochem Soc Trans. 2006;34(Pt 3):446–50. 10.1042/BST0340446
    1. Sanggaard KW, Sonne-Schmidt CS, Krogager TP, et al. : TSG-6 transfers proteins between glycosaminoglycans via a Ser 28-mediated covalent catalytic mechanism. J Biol Chem. 2008;283(49):33919–26. 10.1074/jbc.M804240200
    1. Huang L, Yoneda M, Kimata K: A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter alpha-trypsin inhibitor. J Biol Chem. 1993;268(35):26725–30.
    1. Yingsung W, Zhuo L, Morgelin M, et al. : Molecular heterogeneity of the SHAP-hyaluronan complex. Isolation and characterization of the complex in synovial fluid from patients with rheumatoid arthritis. J Biol Chem. 2003;278(35):32710–8. 10.1074/jbc.M303658200
    1. He H, Li W, Tseng DY, et al. : Biochemical characterization and function of complexes formed by hyaluronan and the heavy chains of inter-alpha-inhibitor (HC*HA) purified from extracts of human amniotic membrane. J Biol Chem. 2009;284(30):20136–46. 10.1074/jbc.M109.021881
    1. de la Motte CA, Hascall VC, Drazba J, et al. : Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am J Pathol. 2003;163(1):121–33. 10.1016/S0002-9440(10)63636-X
    1. Majors AK, Austin RC, de la Motte CA, et al. : Endoplasmic reticulum stress induces hyaluronan deposition and leukocyte adhesion. J Biol Chem. 2003;278(47):47223–31. 10.1074/jbc.M304871200
    1. Lee RT, Yamamoto C, Feng Y, et al. : Mechanical strain induces specific changes in the synthesis and organization of proteoglycans by vascular smooth muscle cells. J Biol Chem. 2001;276(17):13847–51. 10.1074/jbc.M010556200
    1. Ye L, Mora R, Akhayani N, et al. : Growth factor and cytokine-regulated hyaluronan-binding protein TSG-6 is localized to the injury-induced rat neointima and confers enhanced growth in vascular smooth muscle cells. Circ Res. 1997;81(3):289–96. 10.1161/01.RES.81.3.289
    1. Stecco A, Gesi M, Stecco C, et al. : Fascial components of the myofascial pain syndrome. Curr Pain Headache Rep. 2013;17(8):352. 10.1007/s11916-013-0352-9
    1. Okita M, Yoshimura T, Nakano J, et al. : Effects of reduced joint mobility on sarcomere length, collagen fibril arrangement in the endomysium, and hyaluronan in rat soleus muscle. J Muscle Res Cell Motil. 2004;25(2):159–66. 10.1023/B:JURE.0000035851.12800.39
    1. Lieber RL, Steinman S, Barash IA, et al. : Structural and functional changes in spastic skeletal muscle. Muscle Nerve. 2004;29(5):615–27. 10.1002/mus.20059
    1. Julian FJ, Morgan DL: Tension, stiffness, unloaded shortening speed and potentiation of frog muscle fibres at sarcomere lengths below optimum. J Physiol. 1981;319(1):205–17. 10.1113/jphysiol.1981.sp013902
    1. Stecco A, Stecco C, Raghavan P: Peripheral mechanisms contributing to spasticity and implications for treatment. Curr Phys Med Rehabil Rep. 2014;2(2):121–227. 10.1007/s40141-014-0052-3
    1. Song Z, Banks RW, Bewick GS: Modelling the mechanoreceptor's dynamic behaviour. J Anat. 2015;227(2):243–54. 10.1111/joa.12328
    1. Bell J, Holmes M: Model of the dynamics of receptor potential in a mechanoreceptor. Math Biosci. 1992;110(2):139–74. 10.1016/0025-5564(92)90034-T
    1. Suslak TJ, Armstrong JD, Jarman AP: A general mathematical model of transduction events in mechano-sensory stretch receptors. Network. 2011;22(1–4):133–42.
    1. Loewenstein WR, Skalak R: Mechanical transmission in a Pacinian corpuscle. An analysis and a theory. J Physiol. 1966;182(2):346–78. 10.1113/jphysiol.1966.sp007827
    1. Swerup C, Rydqvist B: A mathematical model of the crustacean stretch receptor neuron. Biomechanics of the receptor muscle, mechanosensitive ion channels, and macrotransducer properties. J Neurophysiol. 1996;76(4):2211–20.
    1. Jiang D, Liang J, Noble PW: Hyaluronan as an immune regulator in human diseases. Physiol Rev. 2011;91(1):221–64. 10.1152/physrev.00052.2009
    1. Stern R, Asari AA, Sugahara KN: Hyaluronan fragments: an information-rich system. Eur J Cell Biol. 2006;85(8):699–715. 10.1016/j.ejcb.2006.05.009
    1. Huang Z, Zhao C, Chen Y, et al. : Recombinant human hyaluronidase PH20 does not stimulate an acute inflammatory response and inhibits lipopolysaccharide-induced neutrophil recruitment in the air pouch model of inflammation. J Immunol. 2014;192(11):5285–95. 10.4049/jimmunol.1303060

Source: PubMed

3
Abonneren